These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25505580)

  • 21. A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances.
    Andreasen JT; Redrobe JP; Nielsen EØ; Christensen JK; Olsen GM; Peters D
    Neuropharmacology; 2013 Oct; 73():183-91. PubMed ID: 23748055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
    Papke RL; Schiff HC; Jack BA; Horenstein NA
    Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat nicotinic acetylcholine receptor alpha2beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes.
    Khiroug SS; Khiroug L; Yakel JL
    Neuroscience; 2004; 124(4):817-22. PubMed ID: 15026122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
    Parikh V; Ji J; Decker MW; Sarter M
    J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine.
    Avalos M; Parker MJ; Maddox FN; Carroll FI; Luetje CW
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1246-52. PubMed ID: 12183686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alkaloids indolizidine 235B', quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors.
    Tsuneki H; You Y; Toyooka N; Kagawa S; Kobayashi S; Sasaoka T; Nemoto H; Kimura I; Dani JA
    Mol Pharmacol; 2004 Oct; 66(4):1061-9. PubMed ID: 15258256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
    Broad LM; Zwart R; Pearson KH; Lee M; Wallace L; McPhie GI; Emkey R; Hollinshead SP; Dell CP; Baker SR; Sher E
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1108-17. PubMed ID: 16738207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
    Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
    Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
    Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
    Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R; Salminen O; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptors.
    Faundez-Parraguez M; Farias-Rabelo N; Gonzalez-Gutierrez JP; Etcheverry-Berrios A; Alzate-Morales J; Adasme-Carreño F; Varas R; Bermudez I; Iturriaga-Vasquez P
    Bioorg Med Chem; 2013 May; 21(10):2687-94. PubMed ID: 23561269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line.
    Zheng C; Wang MY; Liu Q; Wakui M; Whiteaker P; Lukas RJ; Wu J
    J Neurochem; 2009 Mar; 108(6):1526-38. PubMed ID: 19183258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.
    Crestey F; Jensen AA; Borch M; Andreasen JT; Andersen J; Balle T; Kristensen JL
    J Med Chem; 2013 Dec; 56(23):9673-82. PubMed ID: 24187998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiating the Neuropharmacological Properties of Nicotinic Acetylcholine Receptor-Activating Alkaloids.
    Alijevic O; Jaka O; Alzualde A; Maradze D; Xia W; Frentzel S; Gifford AN; Peitsch MC; Hoeng J; Koshibu K
    Front Pharmacol; 2022; 13():668065. PubMed ID: 35392565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
    Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
    Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
    Cardoso RA; Brozowski SJ; Chavez-Noriega LE; Harpold M; Valenzuela CF; Harris RA
    J Pharmacol Exp Ther; 1999 May; 289(2):774-80. PubMed ID: 10215652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.